| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| — | — | 1.4 | 0.7 | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1,21,843 | 1,12,966 | 1,17,119 | 3,502 | ||
Expenses | |||||
| — | 8.2 | 12.1 | 13.2 | ||
| 1,18,329 | 1,09,677 | 1,14,124 | — | ||
| 2,713 | 2,537 | 2,493 | 1,758 | ||
| 2,713 | 2,537 | 2,493 | 1,758 | ||
Profit | |||||
| — | — | — | 1,758 | ||
| 2,713 | 2,537 | 2,495 | 1,758 | ||
| 179 | 159 | 198 | — | ||
| 2,656 | 2,470 | 2,413 | 1,721 | ||
| — | 2,470 | 2,413 | 1,721 | ||
Per share | |||||
| ₹26.46 | ₹24.62 | ₹24.07 | — | ||
Revenue detail — as filed | |||||
| 1,320 | 1,297 | 1,114 | — | ||
| 14,955 | 11,062 | 31,714 | — | ||
Expense detail — as filed | |||||
| 242 | 238 | 197 | — | ||
| 3,405 | 3,252 | 2,729 | — | ||
| 4,769 | 4,496 | 3,418 | — | ||
| 4,769 | 4,496 | 3,739 | — | ||
| 142 | 7.9 | −12.2 | — | ||
| 0.9 | 1.0 | 1.2 | — | ||
Profit build-up — alternate / pre-Ind-AS tags | |||||
| 2,713 | 2,537 | 2,495 | — | ||
| 57.4 | 67.1 | 81.4 | — | ||
| 179 | 159 | 198 | — | ||
| 57.4 | 67.1 | 81.4 | — | ||
| 2,656 | 2,470 | 2,413 | — | ||
| 2,656 | 2,470 | 2,413 | — | ||
| 19,104 | 17,830 | 15,631 | — | ||
Per share — as-filed variants | |||||
| ₹5.47 | ₹24.64 | ₹24.09 | — | ||
| ₹5.47 | ₹24.62 | ₹24.07 | — | ||
Appropriations & transfers | |||||
| 19,390 | 18,083 | 15,791 | — | ||
| 0.0 | 0.0 | 0.0 | — | ||
Insurance — revenue account (Policyholders') | |||||
| 1,06,793 | 1,01,286 | 84,985 | — | ||
| 1,04,885 | 99,956 | 84,060 | — | ||
| 23,723 | 21,841 | 19,372 | — | ||
| 62,331 | 58,735 | 49,408 | — | ||
| 20,739 | 20,710 | 16,205 | — | ||
| 2,989 | 2,803 | 1,993 | — | ||
| 1,537 | 1,452 | 1,200 | — | ||
| 243 | 241 | 226 | — | ||
| 11,699 | 10,721 | 8,230 | — | ||
| 6,930 | 6,225 | 4,491 | — | ||
| 27.5 | 29.7 | 34.2 | — | ||
| 59,364 | 54,323 | 48,902 | — | ||
| 46,946 | 43,938 | 55,700 | — | ||
| 2,061 | 2,061 | 1,967 | — | ||
| 24.6 | 29.8 | 93.2 | — | ||
| 806 | 673 | 479 | — | ||
| −2.6 | 525 | 1,106 | — | ||
| 3,514 | 3,289 | 2,994 | — | ||
| 3,514 | 3,289 | 2,994 | — | ||
| 181 | 129 | 255 | — | ||
| 50.5 | 0.2 | 0.3 | — | ||
| — | 55,652 | 49,378 | — | ||
| — | 1,02,120 | 85,440 | — | ||
Insurance — Shareholders' account | |||||
| 1,320 | 1,297 | 1,116 | — | ||
| 4,652 | 4,458 | 3,856 | — | ||
| 1,939 | 1,920 | 1,361 | — | ||
| 38.0 | 16.5 | −19.2 | — | ||
| 3,332 | 3,160 | 2,740 | — | ||
| 1,874 | 1,874 | 1,346 | — | ||
| 3,332 | 3,160 | 2,740 | — | ||
| −0.1 | 0.0 | 0.0 | — | ||
| 0.1 | 0.0 | 0.0 | — | ||
Insurance — result & transfers | |||||
| 6,405 | 6,053 | 5,534 | — | ||
| 129 | 73.9 | −1.2 | — | ||
| — | — | 1.4 | — | ||
| 1,874 | 1,874 | 1,346 | — | ||
Insurance — fund NPAs | |||||
| 0.0 | −0.0 | 0.0 | — | ||
| 0.0 | 0.0 | 0.0 | — | ||
| 0.0 | 0.0 | 0.0 | — | ||
| 0.0 | 0.0 | 0.0 | — | ||
| 0.0 | 0.0 | 0.0 | — | ||
| 0.0 | 0.0 | 0.0 | — | ||
Insurance — IRDAI ratios (as filed, not percentages) | |||||
| 1.90× | 1.90× | 1.96× | — | ||
| ₹1.97 | ₹0.02 | ₹0.02 | — | ||
| ₹0.82 | ₹0.01 | ₹0.01 | — | ||
| ₹0.11 | ₹0.00 | ₹0.00 | — | ||
| ₹0.86 | ₹0.01 | ₹0.01 | — | ||
| ₹0.78 | ₹0.01 | ₹0.01 | — | ||
| ₹0.71 | ₹0.01 | ₹0.01 | — | ||
| ₹0.69 | ₹0.01 | ₹0.01 | — | ||
| ₹0.58 | ₹0.01 | ₹0.01 | — | ||
Direct-method operating receipts — filed in the P&L block | |||||
| — | 0.0 | 1.3 | — | ||
| — | 5,810 | 5,317 | — | ||
Regulatory disclosures — filed alongside, not part of the P&L | |||||
| ₹5.00 | ₹12.00 | ₹35.00 | — | ||
| ₹5.00 | ₹12.00 | ₹35.00 | — | ||
Adjusted (ex-exceptional items) — derived | |||||
| — | — | — | 1,758 | ||
| — | 2,470 | 2,413 | 1,721 | ||
| — | ₹24.62 | ₹24.07 | — | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Other Income | 0.7 | — | 1.4 | — | — | |
| Total Income | 3,502.4 | — | 1,17,118.7 | 1,12,965.9 | 1,21,843.1 | |
| Expenses | ||||||
| + Other Expenses | 13.2 | — | 12.1 | 8.2 | — | |
| Total Expenses | — | — | 1,14,124.2 | 1,09,676.5 | 1,18,329.4 | |
| EBITDA | 1,757.7 | — | 2,493.3 | 2,537.4 | 2,712.9 | |
| EBIT | 1,757.7 | — | 2,493.3 | 2,537.4 | 2,712.9 | |
| Profit | ||||||
| PBT before Exceptional Items | 1,758.4 | — | — | — | — | |
| Pretax Income | 1,758.4 | — | 2,494.7 | 2,537.4 | 2,712.9 | |
| + Current Tax | — | — | 197.9 | 159.5 | 179.0 | |
| Net Income | 1,720.6 | — | 2,413.3 | 2,470.3 | 2,655.5 | |
| + Net Income — Continuing Ops | 1,720.6 | — | 2,413.3 | 2,470.3 | — | |
| Per Share | ||||||
| Basic EPS | — | — | 24.07 | 24.62 | 26.46 | |
| Revenue Detail — as filed | ||||||
| + Investment Income | — | — | 1,114.5 | 1,297.4 | 1,319.6 | |
| + Income from Investments (net) | — | — | 31,714.1 | 11,062.1 | 14,955.5 | |
| Expense Detail — as filed | ||||||
| + Advertisement & Publicity | — | — | 196.6 | 238.1 | 241.9 | |
| + Employee Remuneration & Welfare | — | — | 2,728.8 | 3,251.8 | 3,405.0 | |
| + Commission | — | — | 3,418.2 | 4,495.7 | 4,768.9 | |
| + Commission (net) | — | — | 3,738.8 | 4,495.7 | 4,768.9 | |
| + Provision — Diminution in Investments | — | — | -12.2 | 7.9 | 142.3 | |
| + Provision — Doubtful Debts & Write-offs | — | — | 1.2 | 1.0 | 0.9 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | ||||||
| Profit / (Loss) before Tax | — | — | 2,494.7 | 2,537.4 | 2,712.9 | |
| + Current Taxes | — | — | 81.4 | 67.1 | 57.4 | |
| + Provision for Tax | — | — | 197.9 | 159.5 | 179.0 | |
| + Provisions for Taxes | — | — | 81.4 | 67.1 | 57.4 | |
| PAT before Extraordinary Items | — | — | 2,413.3 | 2,470.3 | 2,655.5 | |
| PAT after Extraordinary Items | — | — | 2,413.3 | 2,470.3 | 2,655.5 | |
| Profit Carried to Balance Sheet | — | — | 15,630.6 | 17,830.1 | 19,104.2 | |
| Per Share — as-filed variants | ||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | — | — | 24.09 | 24.64 | 5.47 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | — | — | 24.07 | 24.62 | 5.47 | |
| Appropriations & Transfers | ||||||
| Reserves & Surplus excl. Revaluation Reserve | — | — | 15,790.7 | 18,083.1 | 19,390.3 | |
| + Interim Dividend | — | — | 0.0 | 0.0 | 0.0 | |
| Insurance — Revenue Account (Policyholders') | ||||||
| + Gross Premium Income | — | — | 84,984.6 | 1,01,286.1 | 1,06,793.1 | |
| + Net Premium Income | — | — | 84,059.8 | 99,955.9 | 1,04,885.0 | |
| + First-year Premium | — | — | 19,371.6 | 21,841.0 | 23,722.9 | |
| + Renewal Premium | — | — | 49,407.8 | 58,734.8 | 62,331.1 | |
| + Single Premium | — | — | 16,205.2 | 20,710.3 | 20,739.2 | |
| + Commission — First-year Premium | — | — | 1,993.1 | 2,802.8 | 2,988.9 | |
| + Commission — Renewal Premium | — | — | 1,199.6 | 1,452.3 | 1,537.0 | |
| + Commission — Single Premium | — | — | 225.6 | 240.7 | 243.1 | |
| + Expenses of Management | — | — | 8,229.5 | 10,721.2 | 11,699.3 | |
| + Operating Expenses — Insurance Business | — | — | 4,490.8 | 6,225.5 | 6,930.4 | |
| + Expenses — Non-insurance | — | — | 34.2 | 29.7 | 27.5 | |
| + Benefits Paid (net) | — | — | 48,901.8 | 54,323.5 | 59,364.2 | |
| + Change in Actuarial Liability | — | — | 55,700.1 | 43,938.2 | 46,946.3 | |
| + Bonus Allocated to Policyholders | — | — | 1,967.2 | 2,060.5 | 2,060.5 | |
| + Interim Bonus Paid | — | — | 93.2 | 29.8 | 24.6 | |
| + Terminal Bonus Paid | — | — | 479.2 | 673.5 | 805.9 | |
| + GST on Linked Charges | — | — | 1,105.8 | 525.3 | -2.6 | |
| Surplus in the Revenue Account | — | — | 2,994.5 | 3,289.4 | 3,513.7 | |
| Net Surplus / (Deficit) | — | — | 2,994.5 | 3,289.4 | 3,513.7 | |
| + Funds for Future Appropriation | — | — | 254.8 | 129.3 | 181.4 | |
| + Policyholders' Liabilities to Shareholders' Fund | — | — | 0.3 | 0.2 | 50.5 | |
| + Payments — Premiums, Claims, Annuities & Benefits | — | — | 49,377.8 | 55,652.2 | — | |
| + Receipts — Premiums, Claims, Annuities & Benefits | — | — | 85,439.5 | 1,02,120.2 | — | |
| Insurance — Shareholders' Account | ||||||
| + Income under Shareholders' Account | — | — | 1,115.9 | 1,297.4 | 1,320.0 | |
| + Shareholders' Account Income | — | — | 3,855.5 | 4,457.5 | 4,652.3 | |
| + Shareholders' Account Expenses | — | — | 1,360.9 | 1,920.1 | 1,939.4 | |
| + Shareholders' Provision — Diminution in Investments | — | — | -19.2 | 16.5 | 38.0 | |
| + Transfer from Policyholders' Account | — | — | 2,739.6 | 3,160.1 | 3,332.3 | |
| + Transfer of Funds to Policyholders' Account | — | — | 1,345.9 | 1,873.9 | 1,873.9 | |
| + Transferred to Shareholders' Account | — | — | 2,739.6 | 3,160.1 | 3,332.3 | |
| Shareholders' Fund — with Unrealised Gains | — | — | 0.0 | 0.0 | -0.1 | |
| Shareholders' Fund — without Unrealised Gains | — | — | 0.0 | 0.0 | 0.1 | |
| Insurance — Result & Transfers | ||||||
| Surplus / (Deficit) | — | — | 5,534.0 | 6,053.2 | 6,404.8 | |
| + Other Income — Policyholders' Account | — | — | -1.2 | 73.9 | 128.7 | |
| + Other Income — Shareholders' Account | — | — | 1.4 | — | — | |
| + Transfer of Funds from Shareholders' Account | — | — | 1,345.9 | 1,873.9 | 1,873.9 | |
| Insurance — Fund NPAs | ||||||
| + Linked Non-participating — with Unrealised Gains | — | — | 0.0 | -0.0 | 0.0 | |
| + Linked Non-participating — without Unrealised Gains | — | — | 0.0 | 0.0 | 0.0 | |
| + Non-linked Participating — with Unrealised Gains | — | — | 0.0 | 0.0 | 0.0 | |
| + Non-linked Participating — without Unrealised Gains | — | — | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — with Unrealised Gains | — | — | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — without Unrealised Gains | — | — | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | ||||||
| Solvency Ratio (x, one scale) | — | — | 1.96 | 1.90 | 1.90 | |
| Solvency Ratio (as filed) | — | — | 0.02 | 0.02 | 1.97 | |
| Conservation Ratio | — | — | 0.01 | 0.01 | 0.82 | |
| Expenses of Management Ratio | — | — | 0.00 | 0.00 | 0.11 | |
| Persistency — 13th Month | — | — | 0.01 | 0.01 | 0.86 | |
| Persistency — 25th Month | — | — | 0.01 | 0.01 | 0.78 | |
| Persistency — 37th Month | — | — | 0.01 | 0.01 | 0.71 | |
| Persistency — 49th Month | — | — | 0.01 | 0.01 | 0.69 | |
| Persistency — 61st Month | — | — | 0.01 | 0.01 | 0.58 | |
| Direct-method Operating Receipts — filed in the P&L block | ||||||
| + Other Operating Cash Receipts | — | — | 1.3 | 0.0 | — | |
| + Other Operating Cash Payments | — | — | 5,317.1 | 5,810.0 | — | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Investor Complaints — Received | — | — | 35.00 | 12.00 | 5.00 | |
| Investor Complaints — Disposed | — | — | 35.00 | 12.00 | 5.00 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||
| Pretax Income (Adjusted, as filed) | 1,758.4 | — | — | — | — | |
| Net Income Adj (tax-effected) | 1,720.6 | — | 2,413.3 | 2,470.3 | — | |
| EPS Adj | — | — | 24.07 | 24.62 | — | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Other Operating Expenses | — | — | 1,565.4 | 2,735.6 | 3,283.5 | |